Skip to content

Medical Innovation Meets Regulatory Excellence

What do U.S. tariffs mean for Canadian medical device companies?

The looming threat of 25% U.S. tariffs imposed on goods from Canada presents significant challenges for medical device companies. Despite lobbying by industry associations on both sides of the border, medical devices — including raw materials and parts — are not exempt. To stay competitive, medical device companies should consider adjusting their global regulatory strategies and explore alternative markets.

1 Items